Samuel McGrath
Beaumont Hospital
16 Papers
198 Citations
Samuel McGrath is an academic researcher from Beaumont Hospital. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 7, co-authored 16 publications.
Chat about Author
Papers
Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis
TL;DR: Employing a VMAT technique decreases treatment times by 37-63%, reducing the chance of error introduced by intrafraction variation, and the quality and efficiency of VMAT is ideally suited for stereotactic lung radiotherapy delivery.
134
Intrafraction Variation of Mean Tumor Position During Image-Guided Hypofractionated Stereotactic Body Radiotherapy for Lung Cancer
TL;DR: The stereotactic frame immobilization device was found to be significantly less likely to have an IFV-MTP vector greater than 2 mm compared with the alpha cradle, BodyFIX, and hybrid immobilization devices.
68
Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?
Jiayi Huang,Frank A. Vicini,Scott Williams,Hong Ye,Samuel McGrath,Mihai Ghilezan,Daniel J. Krauss,Alvaro Martinez,Larry L. Kestin +8 more
TL;DR: The proposed PPC classification appears to provide improved stratification of the clinical outcomes relative to the National Comprehensive Cancer Network classification.
64
PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation.
Samuel McGrath,J. Vito Antonucci,Dwight L. Fitch,Michel Ghilezan,Gary S. Gustafson,Frank A. Vicini,Alvaro Martinez,Larry L. Kestin +7 more
TL;DR: Bounces >or=1.0 ng/ml are rare after brachytherapy with or without neoadjuvant AD, occurring in less than 10% of patients, but as PB amplitude increases, the BF rate increases.
26
Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation.
Samuel McGrath,J.V. Antonucci,Neal S. Goldstein,Michelle Wallace,Chris Mitchell,Inga S. Grills,Shruti Jolly,Larry L. Kestin,Frank A. Vicini +8 more
TL;DR: This analysis demonstrates the inaccuracy of clinically establishing the clonality of most IBTRs, and provides a reliable means of identifying patients who may benefit from aggressive systemic therapy at the time of IBTR and provide an accurate assessment of the efficacy of various forms of local therapy.
24